Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis.

Nys G, Cobraiville G, Servais AC, Malaise MG, de Seny D, Fillet M.

Talanta. 2019 Nov 1;204:507-517. doi: 10.1016/j.talanta.2019.06.044. Epub 2019 Jun 11.

2.

Targeted metabolomics of whole blood using volumetric absorptive microsampling.

Kok MGM, Nix C, Nys G, Fillet M.

Talanta. 2019 May 15;197:49-58. doi: 10.1016/j.talanta.2019.01.014. Epub 2019 Jan 4.

PMID:
30771966
3.

Ultra-high-performance liquid chromatography-mass spectrometry method for neutrophil gelatinase-associated lipocalin as a predictive biomarker in acute kidney injury.

Ion V, Nys G, Cobraiville G, Cavalier E, Crommen J, Servais AC, Muntean DL, Fillet M.

Talanta. 2019 Apr 1;195:668-675. doi: 10.1016/j.talanta.2018.11.050. Epub 2018 Dec 1.

PMID:
30625599
4.

Capillary electrophoresis, high-performance liquid chromatography, and thin-layer chromatography analyses of phenolic compounds from rapeseed plants and evaluation of their antioxidant activity.

Huang Y, Jansen O, Frédérich M, Mouithys-Mickalad A, Nys G, Servais AC, Crommen J, Jiang Z, Fillet M.

J Sep Sci. 2019 Jan;42(2):609-618. doi: 10.1002/jssc.201800712. Epub 2018 Nov 26.

PMID:
30411490
5.

Development of injectable liposomes and drug-in-cyclodextrin-in-liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies.

Palazzo C, Laloy J, Delvigne AS, Nys G, Fillet M, Dogne JM, Pequeux C, Foidart JM, Evrard B, Piel G.

Eur J Pharm Sci. 2019 Jan 15;127:52-59. doi: 10.1016/j.ejps.2018.10.006. Epub 2018 Oct 9. No abstract available.

PMID:
30308312
6.

Microfluidics contribution to pharmaceutical sciences: From drug discovery to post marketing product management.

Nys G, Fillet M.

J Pharm Biomed Anal. 2018 Sep 10;159:348-362. doi: 10.1016/j.jpba.2018.07.011. Epub 2018 Jul 11. Review.

PMID:
30032003
7.

Comparison of nanofluidic and ultra-high performance liquid chromatography-tandem mass spectrometry for high sensitive pharmacokinetic studies of estrogens starting from whole blood microsampling.

Nys G, Cobraiville G, Kok MGM, Wéra O, Servais AC, Fillet M.

J Chromatogr A. 2017 Nov 17;1524:160-168. doi: 10.1016/j.chroma.2017.10.006. Epub 2017 Oct 4.

PMID:
29017723
8.

Validation of a new method by nano-liquid chromatography on chip tandem mass spectrometry for combined quantitation of C3f and the V65 vitronectin fragment as biomarkers of diagnosis and severity of osteoarthritis.

Cobraiville G, Fillet M, Sharif M, Ourradi K, Nys G, Malaise MG, de Seny D.

Talanta. 2017 Jul 1;169:170-180. doi: 10.1016/j.talanta.2017.03.078. Epub 2017 Mar 28.

PMID:
28411808
9.

Whole blood microsampling for the quantitation of estetrol without derivatization by liquid chromatography-tandem mass spectrometry.

Nys G, Gallez A, Kok MGM, Cobraiville G, Servais AC, Piel G, Pequeux C, Fillet M.

J Pharm Biomed Anal. 2017 Jun 5;140:258-265. doi: 10.1016/j.jpba.2017.02.060. Epub 2017 Mar 27.

PMID:
28371720
10.

Sampling only ten microliters of whole blood for the quantification of poorly soluble drugs: Itraconazole as case study.

Thiry J, Evrard B, Nys G, Fillet M, Kok MGM.

J Chromatogr A. 2017 Jan 6;1479:161-168. doi: 10.1016/j.chroma.2016.12.009. Epub 2016 Dec 6.

PMID:
27955892
11.

Rehabilitation of visuospatial neglect by prism adaptation: effects of a mild treatment regime. A randomised controlled trial.

Vaes N, Nys G, Lafosse C, Dereymaeker L, Oostra K, Hemelsoet D, Vingerhoets G.

Neuropsychol Rehabil. 2018 Sep;28(6):899-918. doi: 10.1080/09602011.2016.1208617. Epub 2016 Jul 18.

PMID:
27425388
12.

Impact of injection solvent composition on protein identification in column-switching chip-liquid chromatography/mass spectrometry.

Houbart V, Cobraiville G, Nys G, Merville MP, Fillet M.

J Chromatogr A. 2016 May 6;1445:27-35. doi: 10.1016/j.chroma.2016.03.056. Epub 2016 Mar 24.

PMID:
27063371
13.

Rapid and simple preparation of thiol-ene emulsion-templated monoliths and their application as enzymatic microreactors.

Lafleur JP, Senkbeil S, Novotny J, Nys G, Bøgelund N, Rand KD, Foret F, Kutter JP.

Lab Chip. 2015 May 21;15(10):2162-72. doi: 10.1039/c5lc00224a.

PMID:
25850955
14.

Capturing peripersonal spatial neglect: an electronic method to quantify visuospatial processes.

Vaes N, Lafosse C, Nys G, Schevernels H, Dereymaeker L, Oostra K, Hemelsoet D, Vingerhoets G.

Behav Res Methods. 2015 Mar;47(1):27-44. doi: 10.3758/s13428-014-0448-0.

PMID:
24567147
15.

Exploration of the Raven APM-National Adult Reading Test discrepancy as a measure of intellectual decline in older persons.

van den Berg E, Nys GM, Brands AM, Ruis C, van Zandvoort MJ, Kessels RP.

Appl Neuropsychol Adult. 2013;20(1):7-14. doi: 10.1080/09084282.2012.670148. Epub 2012 Sep 20.

PMID:
23373679
16.

Cognitive differences between patients with left-sided and right-sided Parkinson's disease. A review.

Verreyt N, Nys GM, Santens P, Vingerhoets G.

Neuropsychol Rev. 2011 Dec;21(4):405-24. doi: 10.1007/s11065-011-9182-x. Epub 2011 Sep 29. Review.

PMID:
21956794
17.

Delirium in acute stroke: a predictor of subsequent cognitive impairment? A two-year follow-up study.

van Rijsbergen MW, Oldenbeuving AW, Nieuwenhuis-Mark RE, Nys GM, Las SG, Roks G, de Kort PL.

J Neurol Sci. 2011 Jul 15;306(1-2):138-42. doi: 10.1016/j.jns.2011.03.024. Epub 2011 Apr 9.

PMID:
21481420
18.

Horizontal and vertical attentional orienting in Parkinson's disease.

Nys GM, Santens P, Vingerhoets G.

Brain Cogn. 2010 Dec;74(3):179-85. doi: 10.1016/j.bandc.2010.07.004.

PMID:
20801575
19.

Repetitive long-term prism adaptation permanently improves the detection of contralesional visual stimuli in a patient with chronic neglect.

Nijboer TC, Nys GM, van der Smagt MJ, van der Stigchel S, Dijkerman HC.

Cortex. 2011 Jun;47(6):734-40. doi: 10.1016/j.cortex.2010.07.003. Epub 2010 Jul 11.

PMID:
20691433
20.

The Brixton Spatial Anticipation Test as a test for executive function: validity in patient groups and norms for older adults.

van den Berg E, Nys GM, Brands AM, Ruis C, van Zandvoort MJ, Kessels RP.

J Int Neuropsychol Soc. 2009 Sep;15(5):695-703. doi: 10.1017/S1355617709990269. Epub 2009 Jul 29.

PMID:
19638251
21.

Repetitive exploration towards locations that no longer carry a target in patients with neglect.

Nys GM, Stuart M, Dijkerman HC.

J Neuropsychol. 2010 Mar;4(Pt 1):33-45. doi: 10.1348/174866408X402424. Epub 2009 Feb 17.

PMID:
19338727
22.

A selective deficit in the appreciation and recognition of brightness: brightness agnosia?

Nijboer TC, Nys GM, van der Smagt MJ, de Haan EH.

Cortex. 2009 Jul-Aug;45(7):816-24. doi: 10.1016/j.cortex.2008.12.007. Epub 2009 Jan 31.

PMID:
19243743
23.

Prism adaptation moves neglect-related perseveration to contralesional space.

Nys GM, Seurinck R, Dijkerman HC.

Cogn Behav Neurol. 2008 Dec;21(4):249-53. doi: 10.1097/WNN.0b013e31818a5cc1.

PMID:
19057176
24.

Acute neglect rehabilitation using repetitive prism adaptation: a randomized placebo-controlled trial.

Nys GM, de Haan EH, Kunneman A, de Kort PL, Dijkerman HC.

Restor Neurol Neurosci. 2008;26(1):1-12.

PMID:
18431002
25.

Confabulation behavior and false memories in Korsakoff's syndrome: role of source memory and executive functioning.

Kessels RP, Kortrijk HE, Wester AJ, Nys GM.

Psychiatry Clin Neurosci. 2008 Apr;62(2):220-5. doi: 10.1111/j.1440-1819.2008.01758.x.

26.

Hyperglycemia and cognitive outcome after ischemic stroke.

Kruyt ND, Nys GM, van der Worp HB, van Zandvoort MJ, Kappelle LJ, Biessels GJ.

J Neurol Sci. 2008 Jul 15;270(1-2):141-7. doi: 10.1016/j.jns.2008.02.020. Epub 2008 Apr 2.

PMID:
18387635
27.

Incomplete ipsilesional hallucinations in a patient with neglect.

Nys GM, Nijboer TC, de Haan EH.

Cortex. 2008 Mar;44(3):350-2. doi: 10.1016/j.cortex.2007.10.009. Epub 2007 Dec 27. No abstract available.

PMID:
18387564
28.

Prism adaptation improves voluntary but not automatic orienting in neglect.

Nijboer TC, McIntosh RD, Nys GM, Dijkerman HC, Milner AD.

Neuroreport. 2008 Feb 12;19(3):293-8. doi: 10.1097/WNR.0b013e3282f4cb67.

PMID:
18303569
29.

The perception of emotional facial expressions in stroke patients with and without depression.

Montagne B, Nys GM, van Zandvoort MJ, Kappelle LJ, de Haan EH, Kessels RP.

Acta Neuropsychiatr. 2007 Oct;19(5):279-83. doi: 10.1111/j.1601-5215.2007.00235.x.

PMID:
26952939
30.

The physiological basis of visual hallucinations after damage to the primary visual cortex.

De Haan EH, Nys GM, van Zandvoort MJ, Ramsey NF.

Neuroreport. 2007 Jul 16;18(11):1177-80.

PMID:
17589322
31.

Cognitive disorders in acute stroke: prevalence and clinical determinants.

Nys GM, van Zandvoort MJ, de Kort PL, Jansen BP, de Haan EH, Kappelle LJ.

Cerebrovasc Dis. 2007;23(5-6):408-16. Epub 2007 Apr 2.

PMID:
17406110
32.

Cognitive function following stroke and vascular cognitive impairment.

de Haan EH, Nys GM, Van Zandvoort MJ.

Curr Opin Neurol. 2006 Dec;19(6):559-64. Review.

PMID:
17102694
33.

The modified Location Learning Test: norms for the assessment of spatial memory function in neuropsychological patients.

Kessels RP, Nys GM, Brands AM, van den Berg E, Van Zandvoort MJ.

Arch Clin Neuropsychol. 2006 Dec;21(8):841-6. Epub 2006 Oct 6.

34.

Neuropsychological and neuroanatomical correlates of perseverative responses in subacute stroke.

Nys GM, van Zandvoort MJ, van der Worp HB, Kappelle LJ, de Haan EH.

Brain. 2006 Aug;129(Pt 8):2148-57.

PMID:
16870885
35.

Early cognitive impairment predicts long-term depressive symptoms and quality of life after stroke.

Nys GM, van Zandvoort MJ, van der Worp HB, de Haan EH, de Kort PL, Jansen BP, Kappelle LJ.

J Neurol Sci. 2006 Sep 25;247(2):149-56. Epub 2006 May 22.

PMID:
16716359
36.

Domain-specific cognitive recovery after first-ever stroke: a follow-up study of 111 cases.

Nys GM, Van Zandvoort MJ, De Kort PL, Jansen BP, Van der Worp HB, Kappelle LJ, De Haan EH.

J Int Neuropsychol Soc. 2005 Nov;11(7):795-806.

PMID:
16519259
37.

Cognitive and functional outcome after intravenous recombinant tissue plasminogen activator treatment in patients with a first symptomatic brain infarct.

Nys GM, van Zandvoort MJ, Algra A, Kappelle LJ, de Haan EH.

J Neurol. 2006 Feb;253(2):237-41. Epub 2005 Sep 12.

PMID:
16142581
38.

Early neuropsychological evaluation in patients with ischaemic stroke provides valid information.

van Zandvoort MJ, Kessels RP, Nys GM, de Haan EH, Kappelle LJ.

Clin Neurol Neurosurg. 2005 Aug;107(5):385-92. Epub 2004 Dec 18.

PMID:
16023532
39.

Restrictions of the Mini-Mental State Examination in acute stroke.

Nys GM, van Zandvoort MJ, de Kort PL, Jansen BP, Kappelle LJ, de Haan EH.

Arch Clin Neuropsychol. 2005 Jul;20(5):623-9.

40.

The prognostic value of domain-specific cognitive abilities in acute first-ever stroke.

Nys GM, van Zandvoort MJ, de Kort PL, van der Worp HB, Jansen BP, Algra A, de Haan EH, Kappelle LJ.

Neurology. 2005 Mar 8;64(5):821-7.

PMID:
15753416
41.

The role of executive functioning in spontaneous confabulation.

Nys GM, van Zandvoort MJ, Roks G, Kappelle LJ, de Kort PL, de Haan EH.

Cogn Behav Neurol. 2004 Dec;17(4):213-8.

PMID:
15622017
42.

Early depressive symptoms after stroke: neuropsychological correlates and lesion characteristics.

Nys GM, van Zandvoort MJ, van der Worp HB, de Haan EH, de Kort PL, Kappelle LJ.

J Neurol Sci. 2005 Jan 15;228(1):27-33.

PMID:
15607207
43.

[The Location Learning Test as a measure of spatial memory: applicability of a modified administration procedure and normative data].

Kessels RP, Nys GM, Brands AM, van Zandvoort MJ.

Tijdschr Gerontol Geriatr. 2004 Aug;35(4):147-52. Dutch.

PMID:
15478319
44.

Transient binding by time: Neuropsychological evidence from anti-extinction.

Humphreys GW, Riddoch MJ, Nys G, Heinke D.

Cogn Neuropsychol. 2002 Jun 1;19(4):361-80. doi: 10.1080/02643290143000222.

PMID:
20957544
45.

Gene expression related to the differentiation of osteoblastic cells is altered by microgravity.

Carmeliet G, Nys G, Stockmans I, Bouillon R.

Bone. 1998 May;22(5 Suppl):139S-143S.

PMID:
9600771
46.

Microgravity reduces the differentiation of human osteoblastic MG-63 cells.

Carmeliet G, Nys G, Bouillon R.

J Bone Miner Res. 1997 May;12(5):786-94.

47.
49.

Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells.

Snoeck HW, Van Bockstaele DR, Nys G, Lenjou M, Lardon F, Haenen L, Rodrigus I, Peetermans ME, Berneman ZN.

J Exp Med. 1994 Sep 1;180(3):1177-82.

50.

Mouse macrophage derived monocyte chemotactic protein-3: cDNA cloning and identification as MARC/FIC.

Thirion S, Nys G, Fiten P, Masure S, Van Damme J, Opdenakker G.

Biochem Biophys Res Commun. 1994 Jun 15;201(2):493-9.

PMID:
8002978

Supplemental Content

Support Center